Next Article in Journal
Early Diagnosis of Ovarian Cancer: A Comprehensive Review of the Advances, Challenges, and Future Directions
Next Article in Special Issue
Urinary Fetuin-A with Specific Post-Translational Modification in Type 1 Diabetes Patients with Normoalbuminuria and Preserved Kidney Function
Previous Article in Journal
Diagnosis on Ultrasound Images for Developmental Dysplasia of the Hip with a Deep Learning-Based Model Focusing on Signal Heterogeneity in the Bone Region
Previous Article in Special Issue
Hormones, Age, and Erectile Dysfunction: Should Routine Testing Be Part of the Initial Evaluation?
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a)

by
Dunja Leskovar Lemešić
1,*,
Livija Šimičević
2,3,*,
Lana Ganoci
2,4,
Andrea Gelemanović
5,
Nediljko Šućur
1 and
Ivan Pećin
1,6
1
Division for Metabolic Diseases, Department of Internal Medicine, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
2
Division for Pharmacogenomics and Therapy Individualization, Department of Laboratory Diagnostics, University Hospital Centre Zagreb, 10000 Zagreb, Croatia
3
Department of Medical Chemistry, Biochemistry and Clinical Chemistry, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
4
Department of Basic and Clinical Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
5
Mediterranean Institute for Life Sciences (MedILS), University of Split, 21000 Split, Croatia
6
Department of Internal Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
*
Authors to whom correspondence should be addressed.
Diagnostics 2025, 15(4), 404; https://doi.org/10.3390/diagnostics15040404
Submission received: 2 January 2025 / Revised: 2 February 2025 / Accepted: 6 February 2025 / Published: 7 February 2025
(This article belongs to the Special Issue Exploring the Role of Diagnostic Biochemistry)

Abstract

Background/Objectives: Lipoprotein (a) [Lp(a)] plays a significant role in atherosclerosis and cardiovascular disease (CVD). Genetic regulation of Lp(a) involves variations in the apo(a) LPA gene, as specific polymorphisms like rs10455872 and rs3798220, both linked to higher Lp(a) levels and CVD. CVD remains the leading global cause of death, with high Lp(a) levels increasingly recognized as a significant factor in younger patients with no other CVD risk factors. We aimed to evaluate the association of LPA genetic variations with Lp(a) levels and its effect on cardiovascular risk as there are existing inconsistent findings. Methods: This case–control study included 251 subjects with a median age of 52 years (interquartile range, IQR = 17) and elevated Lp(a) levels. Cases were subjects who experienced early cardiovascular incidents (women < 65, men < 55 years old), and the control group included subjects without such history. Genotyping of LPA gene polymorphisms (rs10455872 and rs3798220) was performed, and demographic data with Lp(a) levels were collected. To evaluate the association between the LPA genotypes and the risk of cardiovascular incidents (CVI), several logistic regression models were performed. The cut-off points for Lp(a) levels were determined using diagnostic test accuracy measures. Results: The rs3798220-C allele was associated with higher Lp(a) levels (288 ± 166 nmol/L in cases vs. 189 ± 102 nmol/L in controls, p < 0.001) and myocardial infarction (53% in cases vs. 36% in controls, p = 0.036). Among cases, 28.9% carried the rs3798220-C allele, compared to 18.7% in controls. The rs10455872-G allele was slightly more prevalent in controls (34.15% vs. 29.69%) but without further significant associations. In this study, the cut-off Lp(a) value of 151 nmol/L, for patients with a positive family history of early CVD, is associated with a higher chance of developing CVI. Conclusions: This study demonstrates an association between the LPA rs3798220-C allele and higher Lp(a) levels, as well as an increased risk of early onset myocardial infarction. However, the obtained association should further be evaluated at a much larger scale.
Keywords: cardiovascular diseases; cardiovascular risk factors; case–control studies; lipoprotein(a); single nucleotide polymorphism cardiovascular diseases; cardiovascular risk factors; case–control studies; lipoprotein(a); single nucleotide polymorphism

Share and Cite

MDPI and ACS Style

Lemešić, D.L.; Šimičević, L.; Ganoci, L.; Gelemanović, A.; Šućur, N.; Pećin, I. Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a). Diagnostics 2025, 15, 404. https://doi.org/10.3390/diagnostics15040404

AMA Style

Lemešić DL, Šimičević L, Ganoci L, Gelemanović A, Šućur N, Pećin I. Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a). Diagnostics. 2025; 15(4):404. https://doi.org/10.3390/diagnostics15040404

Chicago/Turabian Style

Lemešić, Dunja Leskovar, Livija Šimičević, Lana Ganoci, Andrea Gelemanović, Nediljko Šućur, and Ivan Pećin. 2025. "Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a)" Diagnostics 15, no. 4: 404. https://doi.org/10.3390/diagnostics15040404

APA Style

Lemešić, D. L., Šimičević, L., Ganoci, L., Gelemanović, A., Šućur, N., & Pećin, I. (2025). Association of rs3798220 Polymorphism with Cardiovascular Incidents in Individuals with Elevated Lp(a). Diagnostics, 15(4), 404. https://doi.org/10.3390/diagnostics15040404

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop